A physician ordered 1/4 strength Isomil 12 oz via nasogastric tube over 6 hours. How much solvent (water) will be needed?

A) Transdermal patch:
Transdermal patches are designed for slow, continuous delivery of medication through the skin over a long period of time, typically 24 hours. Although they provide steady medication levels, they do not offer a rapid onset of action. This route is more suitable for long-term control of conditions like angina but is not the fastest for immediate relief.

B) Topical ointment:
Topical ointments are applied to the skin and absorb slowly. While they may have local effects, they are not used for quick systemic effects. In the case of nitroglycerin, topical ointments are generally used for sustained release over several hours and are not intended for immediate relief of chest pain.

C) Suspended release:
Suspended release formulations are designed to release the drug slowly over time. Like transdermal patches, these formulations are meant for long-term management, not for rapid onset. A suspended release formulation of nitroglycerin would not provide the immediate relief that is typically needed in cases of acute angina or chest pain.

D) Sublingual:
The sublingual route provides the most rapid onset of action for nitroglycerin. When nitroglycerin is placed under the tongue, it is absorbed directly into the bloodstream through the mucous membranes of the mouth. This bypasses the digestive system and the liver (first-pass metabolism), allowing the drug to take effect quickly—usually within 1 to 3 minutes—making it ideal for acute relief of chest pain or angina. This route is commonly used for emergencies when rapid relief is needed.

A) Neutropenia
Neutropenia refers to an abnormally low level of neutrophils, a type of white blood cell. While certain medications, such as chemotherapy agents and some antipsychotic drugs, can cause neutropenia, atenolol (a beta-blocker) is not typically associated with this side effect. Atenolol primarily affects the cardiovascular system by reducing heart rate and blood pressure, and it is not known to cause significant changes in white blood cell counts.

B) Bradycardia
Bradycardia, or a slower-than-normal heart rate, is a well-known and common adverse effect of beta-blockers, including atenolol. Beta-blockers work by blocking beta-adrenergic receptors, which decreases the heart rate and the force of contraction, as well as lowering blood pressure. In some individuals, this can lead to excessively low heart rates, which could be dangerous if the heart rate drops too much. Bradycardia can lead to symptoms such as dizziness, fainting, or fatigue, and may require dose adjustments or discontinuation of the medication

C) Anemia
Anemia, which is a condition characterized by a low red blood cell count or low hemoglobin levels, is generally not a common adverse effect of atenolol. While certain medications like some chemotherapeutic agents, NSAIDs, or antibiotics may cause anemia due to their effects on the bone marrow or by causing gastrointestinal bleeding, atenolol is not typically linked to this side effect.

D) Hypokalemia
Hypokalemia (low potassium levels) is typically associated with the use of diuretics or other medications that cause the kidneys to excrete more potassium, such as some classes of antibiotics and corticosteroids. However, atenolol, being a beta-blocker, does not directly affect potassium levels.